Appendix — Revision and Evidence Map

Formula and Design Map

A compact map from causal target and counterfactual source to estimator, assumption, diagnostic and scope

Formula and Design Map

Core estimands

NameDefinitionPopulation
ATEE[Y(1)Y(0)]E[Y(1)-Y(0)]declared target population
ATTE[Y(1)Y(0)D=1]E[Y(1)-Y(0)\mid D=1]treated units
ITTE[YZ=1]E[YZ=0]E[Y\mid Z=1]-E[Y\mid Z=0] under random ZZassignment-eligible units
LATEE[Y(1)Y(0)D(1)>D(0)]E[Y(1)-Y(0)\mid D(1)>D(0)]instrument compliers
CATEE[Y(1)Y(0)X=x]E[Y(1)-Y(0)\mid X=x]covariate-defined stratum
policy valueE[Y(π(X))c(X)π(X)]E[Y(\pi(X))-c(X)\pi(X)]decision target under rule π\pi

Always define the treatment version, outcome horizon and unit with the symbol.

Design map

DesignMinimal contrastCounterfactual sourceCentral assumptionPrimary diagnosticUsual scope
randomised offerYˉZ=1YˉZ=0\bar Y_{Z=1}-\bar Y_{Z=0}random assignmentimplemented assignment; attrition controlledbalance process, flow and outcome coverageexperimental population
adjusted regressioncoefficient or standardised prediction contrastconditionally comparable unitsexchangeability, overlap, correct target modelDAG/control and support auditadjustment target
IVRF/FSRF/FSinstrument-induced treatmentindependence, exclusion, relevance, monotonicityfirst stage, weak-IV and exclusion sensitivitycompliers
fixed effectswithin-unit contrastunit over timetime-varying confounding handledtiming, pre-trends, serial dependenceunits with within variation
2×2 DID(YT1YT0)(YC1YC0)(Y_{T1}-Y_{T0})-(Y_{C1}-Y_{C0})comparison trendparallel untreated trends, no anticipationtrends/placebos/sensitivitytreated group and period
staggered DIDaggregate ATT(g,t)ATT(g,t)never/not-yet treatedcohort-specific trendscohort support and simultaneous bandssupported cohorts/horizons
sharp RDDlimc+E[YX]limcE[YX]\lim_{c+}E[Y\mid X]-\lim_{c-}E[Y\mid X]cutoff neighbourscontinuity, no bundled discontinuitydensity, covariates, bandwidthcutoff units
weightingweighted outcome contrastobserved-covariate overlapexchangeability and positivitybalance, weights, neffn_{eff}weighted target
synthetic controlY1tjwjYjtY_{1t}-\sum_jw_jY_{jt}weighted donor trajectorydonor stability and no spilloverspre-fit, placebos, leave-one-outtreated aggregate unit
DMLorthogonal residual scoredesign + flexible nuisance estimationunderlying identification and nuisance ratesoverlap, split/learner stabilitydeclared low-dimensional target

Interpretation map

Reported objectTranslate into
OLS coefficientlinear projection slope conditional on included regressors
logit coefficientconditional log-odds change
eβe^\beta in count modelconditional mean/rate ratio
event-study pointsupported cohort-weighted effect at event time
causal-forest CATEconditional effect estimate with local support/uncertainty
robustness valueviolation strength under a stated sensitivity model

Uncertainty map

Variation sourceStarting reference
individual random assignmentassignment/randomisation or individual sampling
cluster-level policy assignmentcluster-level variation; report cluster count
repeated panel outcomeswithin-unit dependence and assignment level
RDD near cutofflocal-polynomial robust bias-corrected inference
synthetic-control case studyplacebo/permutation and design-specific uncertainty
learned policyhonest out-of-sample value and policy-selection uncertainty

Standard errors are part of the design argument, not a formatting choice.

Next: Worked Pitfalls

Copyright © 2026